GERD Capsule in pharma franchise in Maharashtra

GERD Capsule in PCD pharma franchise in Imphal

GERD Capsule in top pharma company in Madurai

GERD Capsule in pcd pharma supplier in Raipur

GERD Capsule in phama franchise company in India
GERD Capsule in phama distributor in Kota

Home/Products /pantoprazole-e-point-c-point-i-point-p-point-40mg-e-point-c-point-domperidone-capsule

Panpital DUO Capsule

Composition : Pantoprazole (E.C.) I.P. 40mg (E.C.) + Domperidone (I.R.) I.P. 10mg + Domperidone (S.R.) I.P. 20mg Capsules

Dosage Form : Capsule

Packaging Type : blister

Packaging : 10*15

Price : ₹214/-

Panpital DUO Capsule is a combination of Pantoprazole and Domperidone, designed to provide comprehensive relief from digestive disorders. Pantoprazole is a proton pump inhibitor (PPI) that effectively reduces stomach acid production, helping to heal acid-related damage to the stomach and esophagus. It is commonly used in the treatment of conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.

The inclusion of Domperidone, both in immediate-release and sustained-release forms, enhances the therapeutic effect by improving gastrointestinal motility. Domperidone helps to alleviate symptoms of nausea, vomiting, and bloating associated with acid reflux and other gastric disorders. The sustained-release formulation ensures a prolonged action, providing relief over an extended period.

Panpital DUO Capsule is particularly beneficial for individuals suffering from both acid reflux and delayed gastric emptying, as it combines the acid-suppressing action of Pantoprazole with the motility-enhancing effects of Domperidone. It helps in reducing discomfort caused by acid regurgitation, heartburn, and indigestion, and supports faster gastric emptying.

Read More

About the Product

Panpital DUO Capsule is a combination of Pantoprazole and Domperidone, designed to provide comprehensive relief from digestive disorders. Pantoprazole is a proton pump inhibitor (PPI) that effectively reduces stomach acid production, helping to heal acid-related damage to the stomach and esophagus. It is commonly used in the treatment of conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.

The inclusion of Domperidone, both in immediate-release and sustained-release forms, enhances the therapeutic effect by improving gastrointestinal motility. Domperidone helps to alleviate symptoms of nausea, vomiting, and bloating associated with acid reflux and other gastric disorders. The sustained-release formulation ensures a prolonged action, providing relief over an extended period.

Panpital DUO Capsule is particularly beneficial for individuals suffering from both acid reflux and delayed gastric emptying, as it combines the acid-suppressing action of Pantoprazole with the motility-enhancing effects of Domperidone. It helps in reducing discomfort caused by acid regurgitation, heartburn, and indigestion, and supports faster gastric emptying.

Common side effects may include headache, dizziness, abdominal discomfort, dry mouth, and diarrhea. Rare side effects include increased liver enzymes, allergic reactions, and heart palpitations.

Panpital DUO is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, dyspepsia, and conditions requiring acid suppression with delayed gastric emptying.

Use as prescribed. Consult a healthcare professional if symptoms persist or worsen.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation